clodronic acid has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgan, GJ | 1 |
| Bauersachs, J; Bayer, B; Bobinger, T; Ertl, G; Fraccarollo, D; Frantz, S; Hagedorn, I; Hofmann, U; Kneitz, S; Kranepuhl, S; Nahrendorf, M; Nieswandt, B; Pachel, C; Schäfer, A; Schön, MP; Wagner, H; Weidemann, F | 1 |
2 other study(ies) available for clodronic acid and Thrombosis
| Article | Year |
|---|---|
Further analyses of the Myeloma IX Study.
Topics: Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Humans; Imidazoles; Multiple Myeloma; Osteonecrosis; Thrombosis; Zoledronic Acid | 2011 |
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction.
Topics: Animals; Bone Density Conservation Agents; Clodronic Acid; Extracellular Matrix; Female; Heart Ventricles; Humans; Inflammation; Lipopolysaccharide Receptors; Liposomes; Macrophages; Mice; Monocytes; Myocardial Infarction; Receptors, IgG; Thrombosis | 2013 |